Pluvicto is available in Ontario, at least: my oncology team told me about Pluvicto in late 2021 or early 2022 as a future option if/when ADT and Apalutamide stopped working and my cancer became castrate-resistant. As the article says, it's just not available routinely as an *early* intervention yet.

It's possible that because they're a major cancer research centre, they have easier access. They were able to get me special approval for Apalutamide before it was in the Ontario formulary, for example (it took less than a week).